Submit a Manuscript to the Journal
International Journal of Nanomedicine
For an Article Collection on
Advanced Nanomedicine Strategies for Targeted Drug Delivery and Precision Therapeutics
Manuscript deadline
Article Collection Guest Advisor(s)
Prof. Jonghoon Choi,
Chung-Ang University, South Korea
[email protected]
Advanced Nanomedicine Strategies for Targeted Drug Delivery and Precision Therapeutics
The field of nanomedicine has revolutionized the landscape of modern therapeutics by offering unprecedented control over the delivery of pharmaceutical agents. By utilizing engineered nanomaterials, researchers can now navigate complex biological environments to deliver drugs specifically to diseased tissues while minimizing systemic side effects. This Article Collection focuses on the latest breakthroughs in nanocarrier design, including the development of bio-responsive materials, lipid-based nanoparticles, and metallic nanostructures. We aim to explore how these platforms are being refined to improve solubility, stability, and the pharmacokinetic profiles of both small molecules and biologics.
Despite significant laboratory success, the clinical translation of nanomedicine remains a critical challenge. Understanding the interaction between nanomaterials and the biological milieu—such as the protein corona and immune system evasion—is essential for developing effective therapies. This collection is vital because it bridges the gap between fundamental materials science and clinical application. By highlighting strategies that overcome physiological barriers, such as the blood-brain barrier or the dense stroma of solid tumors, this collection provides a roadmap for the next generation of precision medicine that can adapt to individual patient needs.
We invite submissions that cover a broad spectrum of nanomedicine applications, including but not limited to:
- Mitochondrial targeting and organelle-specific delivery.
- Stimuli-responsive drug release mechanisms (pH, temperature, or enzyme-activated).
- Nano-bio interactions and toxicity assessments.
- Scale-up and manufacturing challenges for clinical trials. We welcome Original Research articles, and Comprehensive Reviews. All manuscripts must align with the journal's scope of advancing drug delivery technology.
Please review the journal’s aims and scope and author submission instructions prior to submission.
Please submit your manuscript through the Dovepress website. During submission, enter the promo code 54176 to indicate that your submission is for consideration in this Article Collection.
Please contact Haoyang Yi (Commissioning Editor) at [email protected] with any queries regarding this Article Collection.
Guest Advisor
Prof. Jonghoon Choi, Chung-Ang University
Professor Choi is a full professor at the Chung-Ang University specializing in nanomedicine and biotechnology. His research focuses on the development of advanced drug delivery systems and functional nanomaterials for therapeutic applications. He has published extensively in high-impact journals regarding the medical applications of biodegradable materials and targeted delivery platforms. He is committed to advancing the field of bioengineering through both research and academic leadership.
Benefits of publishing open access within Taylor & Francis
Global marketing and publicity, ensuring your research reaches the people you want it to.
Article Collections bring together the latest research on hot topics from influential researchers across the globe.
Rigorous peer review for every open access article.
Rapid online publication allowing you to share your work quickly.
Submission Instructions
All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this Collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript.